Thu, November 3, 2011
Wed, November 2, 2011
Tue, November 1, 2011
Mon, October 31, 2011
Sat, October 29, 2011
Fri, October 28, 2011
Thu, October 27, 2011
Wed, October 26, 2011
Tue, October 25, 2011
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ]: Market Wire
Cigna to Acquire HealthSpring
Sat, October 22, 2011
Fri, October 21, 2011
Thu, October 20, 2011
Wed, October 19, 2011

Insulet Corporation to Report Third Quarter 2011 Financial Results on November 3, 2011


  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. r-2011-financial-results-on-november-3-2011.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

October 25, 2011 16:15 ET

Insulet Corporation to Report Third Quarter 2011 Financial Results on November 3, 2011

BEDFORD, MA--(Marketwire - Oct 25, 2011) - Insulet Corporation (NASDAQ: [ PODD ]), the leader in [ tubeless insulin pump ] technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the third quarter of 2011 on November 3, 2011 after the close of the financial markets.

Insulet will also host a conference call at 5:00 p.m. Eastern Time on November 3, 2011 to discuss its third quarter 2011 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call, please dial (877) 300-1783 for domestic callers and (832) 412-1780 for international callers. The passcode is 22374966. A replay of the conference call will be available two hours after the start of the call through November 10, 2011 by dialing (855) 859-2056 (domestic) and (404) 537-3406 (international), passcode 22374966. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at [ http://investors.insulet.com ].

About Insulet Corporation
Insulet Corporation (NASDAQ: [ PODD ]) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of [ insulin pump therapy ] among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. Founded in 2000, Insulet Corporation is based in Bedford, Mass. For more information, please visit: [ http://www.myomnipod.com ].



Publication Contributing Sources